<7707> PSS 376 -34

The market has fallen significantly for three consecutive days. The strengthening of regulatory measures related to margin trading by the Tokyo Stock Exchange on the 28th has caused selling pressure to dominate. The commission surveillance deposit rate for new sales and purchases has exceeded 70% (including cash of over 40%). The Japan Securities Clearing Corporation is also strengthening its collection measures for additional collateral. Precision System Science disclosed on the 27th that it will start selling PCR reagents manufactured by SMD GmbH in Germany in the domestic market, but it seems that it has not yet switched to buying.

<4881> Fan Pep 227 +50

The stock price has reached its daily limit. It has been revealed that a patent jointly filed by Fanpep and Osaka University has been registered with the United States Patent and Trademark Office, and it is considered a buying factor. The name of the patent is "Binding vaccine targeting biological proteins that cause diseases", and according to the summary, it is possible to induce effective antibody production using low antigenic proteins. Fanpep has entered into an exclusive license agreement with Osaka University regarding the antibody-inducing peptide "FPP004X" targeting allergies.

<3793> Dricom 1101 +150

Hitting the daily limit. It was announced on the 27th that from spring 25, Disney STEP, a real-life treasure hunting game for smartphones, is planned to be released, and it continues to be considered a buying factor. It is a game app that utilizes location information, allowing players to enjoy treasure hunting with Mickey and others in the game. Ahead of the formal release, player recruitment has started on the official site from the 27th, and a preview will be conducted from September 26.

<4572> Carnaby 423 -21

The stock fell without reaching its peak. Carna Biosciences announced that it has received a patent evaluation from the European Patent Office for a patent jointly filed with Gilead Sciences, its derivation destination, related to a new lipid kinase DGKα inhibitor program created by Carna Biosciences. In addition to receiving milestone payments from Gilead Sciences based on the development progress and market launch of the pharmaceuticals, Carna Biosciences is also entitled to receive royalties based on the revenue after the pharmaceuticals are launched.

<4259> Exawizards 323 -4

Falling short and falling back. To tackle social issues through the use of AI and services, Tohoku Electric Power Company <9506> has announced the start of collaboration. By leveraging Tohoku Electric Power Company's business assets such as data and customer base, as well as Exawizards' digital and AI service planning capabilities, DX human resource development know-how, etc., both parties will work together swiftly to achieve new business and solve social issues. It aims to improve the productivity of companies and organizations in Tohoku and Niigata, and contribute to improving the overall competitiveness of the area.

<6181> Tamenii 123 +1

Continuing the upward trend for 3 days. The company announced that their franchise store for marriage consultation service, 'Partner Agent,' will open its 3rd store in Mito and its 4th store in Hamamatsu on September 6th. They plan to share the knowledge and know-how gained from operating marriage consultation services with franchisees as partners, providing them with the same level of service as directly operated stores. They also aim to accelerate store expansion through the franchise model.